Home > News > Nanobiotech Pioneers Predict Nanomedicine Impact within Five Years
February 11th, 2004
Nanobiotech Pioneers Predict Nanomedicine Impact within Five Years
With nanobiotech research growing at an astounding rate - and funds starting to follow - what are the most promising near-term prospects for nanomedicine? Predicting which applications will have the resources - and luck - to succeed is a dicey proposition, experts acknowledge. But NanoBiotech News posed the questions to the field's preeminent pioneers and found that real-world applications of nanomedicine will happen within five years. Ground-breaking nanotechnology researcher Ralph C. Merkle, Ph.D., and the father of nanomedicine Robert A. Freitas, Jr., JD, are among the industry heavyweights who weighed in with NanoBiotech News on the state of the science and where it's headed.
Innovative strategy to facilitate organ repair April 18th, 2014
Novel stapled peptide nanoparticle combination prevents RSV infection, study finds April 17th, 2014
More effective kidney stone treatment, from the macroscopic to the nanoscale April 17th, 2014
High-temperature plasmonics eyed for solar, computer innovation April 17th, 2014